Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2017-06-29EMA Expired: Sabervel (irbesartan) — Pharmathen S.A.
The EMA page indicates Sabervel (irbesartan) produced by Pharmathen S.A. has expired status in the European market for hypertension.
-
CLINICAL_TRIALS withdrawal · 2017-06-15Clinical Trial Update: The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone [Phase 4]
A Phase 4 trial evaluating chlorthalidone for resistant hypertension in kidney transplant patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-06-09Clinical Trial Update: An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension [Phase 3]
A Phase 3 trial evaluating a fixed-dose combination of candesartan and amlodipine for essential hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-06-05Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DP-R212 [Phase 3]
A Phase 3 clinical trial evaluating DP-R212 for hypertension and hypercholesterolemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-05-30Clinical Trial Update: Effect of Pumpkin Seeds on the Dietary Fatty Acid Intake and Blood Pressure in Women [NA]
A clinical trial evaluating the effect of pumpkin seeds on dietary fatty acids and blood pressure in women has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-05-22Clinical Trial Update: Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil [Phase 3]
A Phase 3 trial evaluating the combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in essential hyperten…
-
CLINICAL_TRIALS withdrawal · 2017-05-15Clinical Trial Update: Study of the Effects of Iron on Lung Blood Pressure at High Altitude [Phase 2]
This Clinical Trial Update indicates that the Phase 2 study of the effects of iron on lung blood pressure at high altitude has been withdraw…
-
EMA withdrawal · 2017-05-11EMA Withdrawn: Imprida (valsartan;amlodipine (as amlodipine besilate)) — Novartis Europharm Ltd
Imprida (valsartan; amlodipine) has been withdrawn from the market.
-
CLINICAL_TRIALS withdrawal · 2017-05-02Clinical Trial Update: Renal Denervation for Treatment of Resistant Hypertension in Patients With Chronic Kidney Disease
The clinical trial investigating renal denervation for resistant hypertension in patients with chronic kidney disease is no longer available…
-
EMA withdrawal · 2017-03-28EMA Withdrawn: Rasilamlo (aliskiren;amlodipine) — Novartis Europharm Ltd
The EMA lists Rasilamlo (aliskiren and amlodipine) as withdrawn from the market.
-
CLINICAL_TRIALS withdrawal · 2017-01-13Clinical Trial Update: Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial [Phase 2, Phase 3]
The clinical trial comparing labetalol to magnesium sulfate for prevention of eclampsia (NCT00293735) has been withdrawn from Phase 2/3 deve…
-
CLINICAL_TRIALS withdrawal · 2016-11-09Clinical Trial Update: Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
A University of Washington-sponsored clinical trial examining gene regions that may influence the effectiveness of antihypertensive drugs ha…
-
CLINICAL_TRIALS withdrawal · 2016-08-11Clinical Trial Update: Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function [Phase 2]
A Phase 2 clinical trial evaluating isosorbide mononitrate for hypertension to improve left ventricular hypertrophy, fibrosis, and myocardia…
-
CLINICAL_TRIALS withdrawal · 2016-07-22Clinical Trial Update: Validation of Pulsewave Blood Pressure Monitor in Hypertensive and Normotensive Pregnant and Postpartum Women
A clinical trial validating a pulsewave blood pressure monitor in hypertensive and normotensive pregnant and postpartum women has been withd…
-
CLINICAL_TRIALS withdrawal · 2016-05-23Clinical Trial Update: Renal Denervation in Treatment Resistant Hypertension [Phase 3]
Phase 3 trial evaluating renal denervation for treatment-resistant hypertension was terminated.
-
CLINICAL_TRIALS withdrawal · 2016-01-26Clinical Trial Update: Evaluation of Effects of Green Coffee Bean Extract (GCE) on Physiological and Psychological Variables [NA]
A clinical trial evaluating the effects of green coffee bean extract on physiological and psychological variables related to blood pressure …
-
CLINICAL_TRIALS withdrawal · 2016-01-20Clinical Trial Update: CSPPT- Chronic Kidney Diseases Study [Phase 4]
Phase 4 CSPPT Chronic Kidney Diseases Study has been withdrawn by the sponsor; the trial evaluated treatment in hypertensive patients with h…
-
CLINICAL_TRIALS withdrawal · 2016-01-12Clinical Trial Update: Safety Study of Nebivolol for COPD Patients [Phase 2, Phase 3]
A Phase 2/Phase 3 safety study of Nebivolol for chronic obstructive pulmonary disease was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-12-29Clinical Trial Update: Home Blood Pressure-guided Antihypertensive Intervention for Elderly (HBP-GUIDE) Study [Phase 4]
A Phase 4 clinical trial evaluating a home blood pressure-guided antihypertensive intervention in elderly participants was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-11-17Clinical Trial Update: Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients
A pilot trial evaluating cardiovascular events in high-risk orthopedic surgical patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-11-02Clinical Trial Update: Long Term Impact of Pediatric Acute Renal Injury in Severe Sepsis
A clinical trial evaluating the long-term effects of pediatric acute kidney injury in severe sepsis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-09Clinical Trial Update: Effect of Stevioside in Postpandrial Glucose in Healthy Adults [NA]
A clinical trial studying the effect of stevioside on postprandial glucose in healthy adults has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-18Clinical Trial Update: Rapid Renal Sympathetic Denervation for Resistant Hypertension II [Phase 2, Phase 3]
Medtronic Endovascular's rapid renal sympathetic denervation trial for resistant hypertension (Phase 2/3) has been withdrawn. The trial was …
-
CLINICAL_TRIALS withdrawal · 2015-06-03Clinical Trial Update: CLCNKA (Ka Renal Chloride Channel[ClC-Ka]) Polymorphism Effects on Hypertrophy Regression [Phase 4]
Phase 4 trial evaluating whether CLCNKA gene polymorphisms influence hypertrophy regression in hypertension was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-03Clinical Trial Update: Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study [Phase 4]
Phase 4 trial evaluating safety and blood pressure lowering with a combined angiotensin receptor blocker and calcium antagonist in hypertens…